183 related articles for article (PubMed ID: 19933623)
1. "Pseudo washout" sign in high-flow hepatic hemangioma on gadoxetic acid contrast-enhanced MRI mimicking hypervascular tumor.
Doo KW; Lee CH; Choi JW; Lee J; Kim KA; Park CM
AJR Am J Roentgenol; 2009 Dec; 193(6):W490-6. PubMed ID: 19933623
[TBL] [Abstract][Full Text] [Related]
2. Hypervascular hepatocellular carcinoma 1 cm or smaller in patients with chronic liver disease: characterization with gadoxetic acid-enhanced MRI that includes diffusion-weighted imaging.
Kim JE; Kim SH; Lee SJ; Rhim H
AJR Am J Roentgenol; 2011 Jun; 196(6):W758-65. PubMed ID: 21606265
[TBL] [Abstract][Full Text] [Related]
3. Peripheral low intensity sign in hepatic hemangioma: diagnostic pitfall in hepatobiliary phase of Gd-EOB-DTPA-enhanced MRI of the liver.
Tamada T; Ito K; Ueki A; Kanki A; Higaki A; Higashi H; Yamamoto A
J Magn Reson Imaging; 2012 Apr; 35(4):852-8. PubMed ID: 22127980
[TBL] [Abstract][Full Text] [Related]
4. Normal dynamic MRI enhancement patterns of the upper abdominal organs: gadoxetic acid compared with gadobutrol.
Kühn JP; Hegenscheid K; Siegmund W; Froehlich CP; Hosten N; Puls R
AJR Am J Roentgenol; 2009 Nov; 193(5):1318-23. PubMed ID: 19843748
[TBL] [Abstract][Full Text] [Related]
5. Hepatic hemangiomas: evaluation of enhancement patterns at dynamic MRI with gadoxetate disodium.
Tamada T; Ito K; Yamamoto A; Sone T; Kanki A; Tanaka F; Higashi H
AJR Am J Roentgenol; 2011 Apr; 196(4):824-30. PubMed ID: 21427331
[TBL] [Abstract][Full Text] [Related]
6. Hepatic hemangioma and metastasis: differentiation with gadoxetate disodium-enhanced 3-T MRI.
Goshima S; Kanematsu M; Watanabe H; Kondo H; Shiratori Y; Onozuka M; Moriyama N
AJR Am J Roentgenol; 2010 Oct; 195(4):941-6. PubMed ID: 20858822
[TBL] [Abstract][Full Text] [Related]
7. High-flow haemangiomas versus hypervascular hepatocellular carcinoma showing "pseudo-washout" on gadoxetic acid-enhanced hepatic MRI: value of diffusion-weighted imaging in the differential diagnosis of small lesions.
Nam SJ; Yu JS; Cho ES; Kim JH; Chung JJ
Clin Radiol; 2017 Mar; 72(3):247-254. PubMed ID: 27789027
[TBL] [Abstract][Full Text] [Related]
8. Hepatic hemangiomas: difference in enhancement pattern on 3T MR imaging with gadobenate dimeglumine versus gadoxetate disodium.
Gupta RT; Marin D; Boll DT; Husarik DB; Davis DE; Feuerlein S; Merkle EM
Eur J Radiol; 2012 Oct; 81(10):2457-62. PubMed ID: 22138122
[TBL] [Abstract][Full Text] [Related]
9. Gadoxetic acid-enhanced hepatobiliary phase MRI and high-b-value diffusion-weighted imaging to distinguish well-differentiated hepatocellular carcinomas from benign nodules in patients with chronic liver disease.
Lee MH; Kim SH; Park MJ; Park CK; Rhim H
AJR Am J Roentgenol; 2011 Nov; 197(5):W868-75. PubMed ID: 22021534
[TBL] [Abstract][Full Text] [Related]
10. [The dynamic magnetic resonance study of focal liver lesions by FLASH sequences with bolus intravenous gadolinium-DTPA].
Olivetti L; Grazioli L; Maroldi R; Matricardi L; Milanesio L
Radiol Med; 1992 Apr; 83(4):353-60. PubMed ID: 1318558
[TBL] [Abstract][Full Text] [Related]
11. Typical and atypical imaging findings of intrahepatic cholangiocarcinoma using gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging.
Kim SH; Lee CH; Kim BH; Kim WB; Yeom SK; Kim KA; Park CM
J Comput Assist Tomogr; 2012; 36(6):704-9. PubMed ID: 23192208
[TBL] [Abstract][Full Text] [Related]
12. Gadoxetic acid-enhanced magnetic resonance imaging for differentiating small hepatocellular carcinomas (< or =2 cm in diameter) from arterial enhancing pseudolesions: special emphasis on hepatobiliary phase imaging.
Sun HY; Lee JM; Shin CI; Lee DH; Moon SK; Kim KW; Han JK; Choi BI
Invest Radiol; 2010 Feb; 45(2):96-103. PubMed ID: 20057319
[TBL] [Abstract][Full Text] [Related]
13. Conspicuity of liver hemangiomas: short tau inversion recovery, T1, and T2 imaging with gadolinium ethoxybenzyl diethylenetriaminepentaacetic acid.
Brody JM; Schafer L; Tung GA; Breuer J; Shamsi K
J Magn Reson Imaging; 2005 Apr; 21(4):391-7. PubMed ID: 15778951
[TBL] [Abstract][Full Text] [Related]
14. Distinguishing hemangiomas from malignant solid hepatic lesions: a comparison of heavily T2-weighted images obtained before and after administration of gadoxetic acid.
Ahn SJ; Kim MJ; Hong HS; Kim KA; Song HT
J Magn Reson Imaging; 2011 Aug; 34(2):310-7. PubMed ID: 21598345
[TBL] [Abstract][Full Text] [Related]
15. Distinguishing hepatic metastasis from hemangioma using gadoxetic acid-enhanced magnetic resonance imaging.
Motosugi U; Ichikawa T; Onohara K; Sou H; Sano K; Muhi A; Araki T
Invest Radiol; 2011 Jun; 46(6):359-65. PubMed ID: 21427594
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the Enhancement Pattern of Hepatic Hemangioma on Magnetic Resonance Imaging Performed With Gd-EOB-DTPA Versus Gd-BOPTA.
Vernuccio F; Bruno A; Costanzo V; Bartolotta TV; Vieni S; Midiri M; Salvaggio G; Brancatelli G
Curr Probl Diagn Radiol; 2020; 49(6):398-403. PubMed ID: 31253462
[TBL] [Abstract][Full Text] [Related]
17. Dynamic and delayed contrast enhancement in upper abdominal MRI studies: comparison of gadoxetic acid and gadobutrol.
Zizka J; Klzo L; Ferda J; Mrklovský M; Bukac J
Eur J Radiol; 2007 May; 62(2):186-91. PubMed ID: 17367974
[TBL] [Abstract][Full Text] [Related]
18. Small hypervascular hepatocellular carcinoma: limited value of portal and delayed phases on dynamic magnetic resonance imaging.
Yu JS; Lee JH; Chung JJ; Kim JH; Kim KW
Acta Radiol; 2008 Sep; 49(7):735-43. PubMed ID: 18608015
[TBL] [Abstract][Full Text] [Related]
19. T2-weighted magnetic resonance imaging of the liver: evaluation of the effect in signal intensity after Gd-EOB-DTPA enhancement.
Tamada T; Ito K; Yoshida K; Sone T; Murakami K; Kanki A; Watanabe S; Higashi H; Yamashita T
J Comput Assist Tomogr; 2010; 34(2):182-6. PubMed ID: 20351500
[TBL] [Abstract][Full Text] [Related]
20. The usefulness of 1.5 harmonic imaging ultrasonography with Levovist in the diagnosis of focal hepatic tumors.
Yamamoto K; Shiraki K; Nakanishi S; Fuke H; Hashimoto A; Shimizu A; Nakano T
Int J Oncol; 2005 Oct; 27(4):989-95. PubMed ID: 16142315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
